Cited by 240Treatment of Major DepressionMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Side effects of antidepressants during long-term use in a naturalistic setting

Open access

Bet, Pierre M., Hugtenburg, Jacqueline G., Penninx, Brenda W.J.H., Hoogendijk, Witte J.G.·2013·European Neuropsychopharmacology

DOI 10.1016/j.euroneuro.2013.05.001

Open this paper in CoChat — free account Open PDF

Abstract

Side effects of antidepressants are usually underreported in clinical trials and large scale naturalistic studies are restricted to six months of use. We examined the prevalence and nature of patient-perceived side effects and their determinants during long-term antidepressant use in a naturalistic setting. Subjects, aged 19 to 67 years, in the Netherlands Study of Depression and Anxiety were recruited from primary care and specialized mental health care covered 927 cases of single antidepressant use. In 64% of cases, on average, 2.9 side effects were reported. The number of side effects was higher when subjects had higher depression severity (OR=1.28; p=0.002), three or more psychiatric diagnoses (OR=1.97; p=0.02), higher dose (OR=1.44; p=0.006) and was lower when subjects were older (OR=0.83; p=0.02) and had longer duration of use (OR=0.94; p=0.04). Tricyclic antidepressants were associated with more side effects (OR=2.52; p=0.003) and, particularly, more anticholinergic effects, like dry mouth and constipation, as compared to selective serotonin reuptake inhibitors. Venlafaxine showed more profuse sweating (OR=1.79; p=0.007), whereas mirtazapine showed more weight gain and less sexual dysfunction (OR=0.36; p=0.03), as compared to selective serotonin reuptake inhibitors. Weight gain was associated with female gender (OR=1.76; p=0.004) and duration of use (OR=1.06; p=0.03). We show that antidepressant side effect, known from short-term studies, persist during long-term use and are associated with depression severity and antidepressant dose. A novel finding was that venlafaxine is associated with more profuse sweating and that weight gain appeared more specific in female users. Clinicians should be aware that, during long-term antidepressant use, side effects are common and persistent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.euroneuro.2013.05.001

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Short screening scales to monitor population prevalences and trends in non-specific psychological distress
KESSLER, R. C., ANDREWS, G., COLPE, L. J., HIRIPI, E., MROCZEK, D. K., NORMAND, S.-L. T., WALTERS, E. E., & ZASLAVSKY, A. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006074 · Cited by 10,327
Screening for serious mental illness in the general population
Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., Howes, M. J., Normand, S.-L. T., Manderscheid, R. W., Walters, E. E., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.184 · Cited by 5,692
Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review
Wittchen, H.-U. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90036-1 · Cited by 2,348
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods
Penninx, B. W. J. H., Beekman, A. T. F., Smit, J. H., Zitman, F. G., Nolen, W. A., Spinhoven, P., Cuijpers, P. J., de Jong, P. J., van Marwijk, H., Assendelft, W. J., et al. (2008) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.256 · Cited by 930
Self-citation
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Treatment non‐adherence in affective disorders
Lingam, R., & Scott, J. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.1r084.x · Cited by 635
Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis
Serretti, A., & Mandelli, L. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05346blu · Cited by 621 · cited 1×
“A recent meta-analysis showed large differences in weight gain between individuals as the result of treatment with various antidepressants (Serretti and Mandelli, 2010).”

Show all 38 references

Research works printed but not linked: 1

American Psychiatric Association, 2001. Diagnostic and Statistical Manual of Mental Disorders, fourth edition, Washington.

Sorted by citations

Depression and obesity: evidence of shared biological mechanisms
Milaneschi, Y., Simmons, W. K., van Rossum, E. F. C., & Penninx, B. W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0017-5 · Cited by 1,073
Self-citation
Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential
Fried, E. I., & Nesse, R. M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0325-4 · Cited by 981
Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care
Tick, H., Nielsen, A., Pelletier, K. R., Bonakdar, R. A., Simmons, S., Glick, R. M., Ratner, E. F., Lemmon, R., Wayne, P. M., & Zador, V. (2018) · EXPLORE · doi:10.1016/j.explore.2018.02.001 · Cited by 404
Measuring depression over time … Or not? Lack of unidimensionality and longitudinal measurement invariance in four common rating scales of depression
Fried, E. I., van Borkulo, C. D., Epskamp, S., Schoevers, R. A., Tuerlinckx, F., & Borsboom, D. (2016) · Psychological Assessment · doi:10.1037/pas0000275 · Cited by 314
Salivary hypofunction: An update on aetiology, diagnosis and therapeutics
Saleh, J., Figueiredo, M. A. Z., Cherubini, K., & Salum, F. G. (2015) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.10.004 · Cited by 237
Long-term antidepressant use: patient perspectives of benefits and adverse effects
Cartwright, C., Gibson, K., Read, J., Cowan, O., & Dehar, T. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s110632 · Cited by 242
Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms
Hu, L.-Y., Mi, W., Wu, G.-C., Wang, Y.-Q., & Mao‐Ying, Q. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915143217 · Cited by 179
Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study
Webb, C. A., Trivedi, M. H., Cohen, Z. D., Dillon, D. G., Fournier, J. C. J., Goer, F., D, M. F. M., McGrath, P. J., Weissman, M. M., Parsey, R. V., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718001708 · Cited by 177
Cardiometabolic effects of psychotropic medications
Abosi, O. J., Lopes, S., Schmitz, S. L., & Fiedorowicz, J. G. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0065 · Cited by 135
The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
Wallace, C. J. K., & Milev, R. V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.618279 · Cited by 130
Weight gain and associated factors in patients using newer antidepressant drugs
Uğuz, F., Şahingöz, M., Güngör, B. B., Aksoy, F., & Aşkın, R. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.10.011 · Cited by 106
Food‐derived hydrophilic antioxidant ergothioneine is distributed to the brain and exerts antidepressant effect in mice
Nakamichi, N., Nakayama, K., Ishimoto, T., Masuo, Y., Wakayama, T., Sekiguchi, H., Sutoh, K., Usumi, K., Iseki, S., & Kato, Y. (2016) · Brain and Behavior · doi:10.1002/brb3.477 · Cited by 107
Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009
Park, R., Mikami, S., LeClair, J., Bollom, A., Lembo, C., Sethi, S., Lembo, A. J., Jones, M., Cheng, V. C., Friedlander, E., et al. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12542 · Cited by 98
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
Atmaca, M. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s185757 · Cited by 89
Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment
Gaspersz, R., Lamers, F., Kent, J. M., Beekman, A. T. F., Smit, J. H., van Hemert, A. M., Schoevers, R. A., & Penninx, B. W. J. H. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.018 · Cited by 88
Self-citation
The Role of Hypothalamic Inflammation in Diet-Induced Obesity and Its Association with Cognitive and Mood Disorders
Dionysopoulou, S., Charmandari, E., Bargiota, Α., Vlahos, N., Mastorakos, G. P., & Valsamakis, G. (2021) · Nutrients · doi:10.3390/nu13020498 · Cited by 91
The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition
Guy, A., Brown, M., Lewis, S., & Horowitz, M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967183 · Cited by 77
Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care
Bosman, R. C., Huijbregts, K. M., Verhaak, P. F., Ruhé, H. G., van Marwijk, H. W., van Balkom, A. J., & Batelaan, N. M. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x686641 · Cited by 76
Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stress
Wang, C., Guo, J., & Guo, R. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1543-9 · Cited by 73
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement
Dodd, S., Mitchell, P. B., Bauer, M., Yatham, L. N., Young, A. H., Kennedy, S. H., Williams, L. J., Suppes, T. M., López‐Jaramillo, C., Trivedi, M. H., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1379609 · Cited by 66
Orphan G Protein Coupled Receptors in Affective Disorders
Watkins, L. R., & Orlandi, C. (2020) · Genes · doi:10.3390/genes11060694 · Cited by 71
Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response.
Dreimüller, N., Lieb, K., Tadić, A., Engelmann, J., Wollschläger, D., & Wagner, S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.067 · Cited by 60
Causes of drug discontinuation in patients with major depressive disorder in China
Zhu, Y., Wu, Z., Sie, O., Cai, Y., Huang, J., Liu, H., Yao, Y., Niu, Z., Wu, X., Shi, Y., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109755 · Cited by 62
Managing the side effects associated with commonly used treatments for bipolar depression
Kemp, D. E. (2014) · Journal of Affective Disorders · doi:10.1016/s0165-0327(14)70007-2 · Cited by 68
Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence
Zhu, J., Klein‐Fedyshin, M., & Stevenson, J. (2017) · Pharmacotherapy · doi:10.1002/phar.1978 · Cited by 52
Mums on the Move: A pilot randomised controlled trial of a home-based physical activity intervention for mothers at risk of postnatal depression
Teychenne, M. J., Abbott, G., Stephens, L. D., Opie, R., Olander, E. K., Brennan, L., van der Pligt, P., Apostolopoulos, M., & Ball, K. (2020) · Midwifery · doi:10.1016/j.midw.2020.102898 · Cited by 57
The psychedelic afterglow phenomenon: A systematic review of subacute effects of classic serotonergic psychedelics
Evens, R., Schmidt, M. E., Majić, T., & Schmidt, T. T. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231172254 · Cited by 56
“76 The studies reported here investigated single uses of psychedelics, reporting on transient subacute side effects.”
Background
Serotonin transporter deficiency drives estrogen-dependent obesity and glucose intolerance
Zha, W., Ho, H. T. B., Hu, T., Hébert, M. F., & Wang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01291-5 · Cited by 58
Gut Microbiota: A Pivotal Hub for Polyphenols as Antidepressants
Zhou, N., Gu, X., Zhuang, T., Xu, Y., Yang, L., & Zhou, M. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01461 · Cited by 54
Clozapine and Gastrointestinal Hypomotility
Cohen, D. (2017) · CNS Drugs · doi:10.1007/s40263-017-0481-5 · Cited by 52
Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis
Meister, R., von Wolff, A., Mohr, H., Härter, M. C., Nestoriuc, Y., Hölzel, L. P., & Kriston, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153380 · Cited by 54
The gut microbiota, HPA axis, and brain in adolescent-onset depression: Probiotics as a novel treatment
Freimer, D., Yang, T. T., Ho, T. C., Tymofiyeva, O., & Leung, C. Y. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100541 · Cited by 60
The brain-gut-microbiota axis in the treatment of neurologic and psychiatric disorders
Naufel, M. F., Truzzi, G., Ferreira, C. M., & Coelho, F. M. S. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1767818 · Cited by 70
‘In my life antidepressants have been…’: a qualitative analysis of users’ diverse experiences with antidepressants
Gibson, K., Cartwright, C., & Read, J. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0844-3 · Cited by 43
Efficacy of a standardised saffron extract (affron®) as an add-on to antidepressant medication for the treatment of persistent depressive symptoms in adults: A randomised, double-blind, placebo-controlled study
Lopresti, A. L., Smith, S. J., Hood, S. D., & Drummond, P. D. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119867703 · Cited by 47
The Effects of Probiotics on Symptoms of Depression: Protocol for a Double-Blind Randomized Placebo-Controlled Trial
Wallace, C. J. K., Foster, J. A., Soares, C. N., & Milev, R. V. (2019) · Neuropsychobiology · doi:10.1159/000496406 · Cited by 50
New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?
Beard, E., Shahab, L., Cummings, D. M., Michie, S., & West, R. (2016) · CNS Drugs · doi:10.1007/s40263-016-0362-3 · Cited by 44
Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation
Manosso, L. M., Moretti, M., Ribeiro, C. M., Gonçalves, F. M., Leal, R. B., & Rodrigues, A. L. S. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.008 · Cited by 43
The effects of inhalation aromatherapy with rose and lavender at week 38 and postpartum period on postpartum depression in high-risk women referred to selected health centers of Yazd, Iran in 2015
Moshirenia, F., Kianpour, M., Kheirabadi, G., Asghari, G., Dehghani, A., & Tafti, A. D. (2018) · Iranian Journal of Nursing and Midwifery Research · doi:10.4103/ijnmr.ijnmr_116_16 · Cited by 40
Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy
Avallone, A., Bimonte, S., Cardone, C., Cascella, M., & Cuomo, A. (2022) · Anticancer Research · doi:10.21873/anticanres.15971 · Cited by 39
Competing priorities in treatment decision-making: a US national survey of individuals with depression and clinicians who treat depression
Barr, P. J., Forcino, R. C., Mishra, M. K., Blitzer, R., & Elwyn, G. J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009585 · Cited by 38
Effectiveness of a Transdiagnostic guided internet-delivered protocol for emotional disorders versus treatment as usual in specialized care: randomized controlled trial
González-Robles, A., Díaz-García, A., García-Palacios, A., Roca, P., Ramos-Quiroga, J. A., & Botella, C. (2020) · Journal of Medical Internet Research · doi:10.2196/18220 · Cited by 40
Does Chinese calligraphy therapy reduce neuropsychiatric symptoms: a systematic review and meta-analysis
Chu, K.-Y., Huang, C., & Ouyang, W. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1611-4 · Cited by 37
Potential of Natural Products of Herbal Origin as Monoamine Oxidase Inhibitors
Orhan, İ. E. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612822666151112150612 · Cited by 37
Antidepressant treatment for primary care patients with depressive symptoms: Data from the diamond longitudinal cohort study
Davidson, S. K., Romaniuk, H., Chondros, P., Dowrick, C. F., Pirkis, J., Herrman, H., Fletcher, S. L., & Gunn, J. M. (2020) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419898761 · Cited by 32
The acute affective response to physical activity in people with depression: A meta-analysis
Bourke, M., Patten, R. K., Klamert, L., Pogrmilović, B. K., Dash, S. R., & Pascoe, M. C. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.089 · Cited by 38
Discontinuation of antidepressant treatment: a retrospective cohort study on more than 20,000 participants
García‐Marín, L. M., Mulcahy, A., Byrne, E. M., Medland, S. E., Wray, N. R., Chafota, F., Lind, P. A., Martin, N. G., Hickie, I. B., Rentería, M. E., et al. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00480-z · Cited by 39
Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stop
Horowitz, M., & Wilcock, M. (2022) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2020.000080 · Cited by 33
Harnessing placebo: Lessons from psychedelic science
Pronovost-Morgan, C., Hartogsohn, I., & Ramaekers, J. G. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231182602 · Cited by 39
Natural Polyphenols and Terpenoids for Depression Treatment: Current Status
Ramos-Hryb, A. B., Cunha, M. P., Kaster, M. P., & Rodrigues, A. L. S. (2017) · Studies in natural products chemistry · doi:10.1016/b978-0-444-64068-0.00006-1 · Cited by 29
Pre-treatment Resting-State Functional MR Imaging Predicts the Long-Term Clinical Outcome After Short-Term Paroxtine Treatment in Post-traumatic Stress Disorder
Yuan, M., Qiu, C., Meng, Y., Ren, Z., Yuan, C., Li, Y., Gao, M., Lui, S., Zhu, H., Gong, Q., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00532 · Cited by 31
‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
Leeuwen, E. V., Anthierens, S., van Driel, M., Sutter, A. D., van den Branden, E., & Christiaens, T. (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.2006487 · Cited by 29
Long-term antidepressant use in general practice: a qualitative study of GPs’ views on discontinuation
Donald, M., Partanen, R. L., Sharman, L. S., Lynch, J. M., Dingle, G. A., Haslam, C., & van Driel, M. (2021) · British Journal of General Practice · doi:10.3399/bjgp.2020.0913 · Cited by 30
Resveratrol attenuates early life stress induced depression in rats: Behavioural and neurochemical evidence
Shukla, P., Akotkar, L., & Aswar, U. M. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137606 · Cited by 26
Effects of cholecalciferol on behavior and production of reactive oxygen species in female mice subjected to corticosterone-induced model of depression
Souza, S. V. D. S., da Rosa, P. B., Neis, V. B., Moreira, J. D., Rodrigues, A. L. S., & Moretti, M. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01714-2 · Cited by 26
The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication
Cohen, Z. D., DeRubeis, R. J., Hayes, R., Watkins, E. R., Lewis, G., Byng, R., Byford, S., Crane, C., Kuyken, W., Dalgleish, T., et al. (2023) · Clinical Psychological Science · doi:10.1177/21677026221076832 · Cited by 25
Pathophysiology of Depression: Stingless Bee Honey Promising as an Antidepressant
Zakaria, F. H., Ismail, S., Mustafa, M. Z., & Shafin, N. (2022) · Molecules · doi:10.3390/molecules27165091 · Cited by 28
The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative
Stanford, F. C., Cena, H., Biino, G., Umoren, O., Jiménez, M. C., Freeman, M. P., Shadyab, A. H., Wild, R. A., Womack, C. R., Banack, H. R., et al. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001589 · Cited by 24
Feasibility and acceptability of a home-based physical activity program for postnatal women with depressive symptoms: A pilot study
Teychenne, M. J., van der Pligt, P., Abbott, G., Brennan, L., & Olander, E. K. (2018) · Mental health and physical activity · doi:10.1016/j.mhpa.2018.02.007 · Cited by 24
Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis
Krijnen-de Bruin, E., Scholten, W., Muntingh, A., Maarsingh, O., van Meijel, B., van Straten, A., & Batelaan, N. (2022) · PLOS ONE · doi:10.1371/journal.pone.0272200 · Cited by 23
“sexual dysfunction, dry mouth) [38] might be reluctant to adhere to ADM during asymptomatic periods [39].”
Background
Sex and Quality of Life
Greenberg, J. M., Smith, K. P., Kim, T. Y., Naghdechi, L., & IsHak, W. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-52539-6_34 · Cited by 23
Physical activity in secure settings: A scoping review of methods, theory and practise
Rogers, E. N., Kinnafick, F., & Papathomas, A. (2018) · Mental health and physical activity · doi:10.1016/j.mhpa.2018.11.004 · Cited by 22
Efficacy and Safety of Citalopram in Treating Post-Stroke Depression: A Meta-Analysis
Tan, S., Huang, X., Ding, L., & Hong, H. (2015) · European Neurology · doi:10.1159/000441446 · Cited by 22
Pharmaco-epidemiology of antidepressant exposure in a UK cohort record-linkage study
Hafferty, J. D., Wigmore, E. M., Howard, D. M., Adams, M. J., Clarke, T., Campbell, A., MacIntyre, D. J., Nicodemus, K. K., Lawrie, S. M., Porteous, D. J., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119827888 · Cited by 22
Enhancing shared decision making about discontinuation of antidepressant medication: a concept-mapping study in primary and secondary mental health care
Wentink, C., Huijbers, M. J., Lucassen, P. L., van der Gouw, A., Kramers, C., Spijker, J., & Speckens, A. E. (2019) · British Journal of General Practice · doi:10.3399/bjgp19x706001 · Cited by 19
Identification of the main active antidepressant constituents in a traditional Turkish medicinal plant, Centaurea kurdica Reichardt
Dereli, F. T. G., İlhan, M., & Akkol, E. K. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112373 · Cited by 21
New insights on the role of the retina in diagnostic and therapeutic strategies in major depressive disorder
Cosker, E., Schwan, R., Angioï-Duprez, K., Laprévote, V., & Schwitzer, T. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.006 · Cited by 21
The efficacy of primary care chaplaincy compared with antidepressants: a retrospective study comparing chaplaincy with antidepressants
Macdonald, G. (2017) · Primary Health Care Research & Development · doi:10.1017/s1463423617000159 · Cited by 20
The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature
Nicholson, W., Kempf, M., Moneyham, L. D., & Vance, D. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s136065 · Cited by 19
Is mapping borders between pharmacology and toxicology a necessity?
Ghanemi, A. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2014.03.001 · Cited by 21
Mortality, disability, psychiatric treatment and medication in first-onset schizophrenia in Finland : the register linkage study
Kiviniemi, M. (2014) · Cited by 20
Barriers of Chinese primary care attenders to seeking help for psychological distress in Hong Kong
Sun, K. S., Lam, T. P., Lam, K. F., Lo, T. L., Chao, D. V. K., & Lam, E. W. W. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.041 · Cited by 20
A simple poly(styrene-co-divinylbenzene)-coated glass blood spot method for monitoring of seven antidepressants using capillary liquid chromatography-mass spectrometry
Murtada, K., de Andrés, F., Ríos, Á., & Zougagh, M. (2018) · Talanta · doi:10.1016/j.talanta.2018.06.059 · Cited by 20
A New Methodology to Create Polymeric Nanocarriers Containing Hydrophilic Low Molecular-Weight Drugs: A Green Strategy Providing a Very High Drug Loading
Villamizar‐Sarmiento, M. G., Molina-Soto, E. F., Guerrero, J., Shibue, T., Nishide, H., Moreno‐Villoslada, I., & Oyarzun-Ampuero, F. A. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00097 · Cited by 20
Prevalence and risk of developing comorbid conditions in patients with chronic constipation
Mody, R., Guérin, A., Fok, B., Lasch, K. L., Zhou, Z., Wu, E. Q., Zhou, W., & Talley, N. J. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.964854 · Cited by 21
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
Soini, E. J., Hallinen, T., Brignone, M., Campbell, R., Diamand, F., Cure, S., Aalto-Setälä, M., Danchenko, N., Koponen, H., & Kolasa, K. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1240617 · Cited by 20
Raising the Minimum Effective Dose of Serotonin Reuptake Inhibitor Antidepressants: Adverse Drug Events
Safer, D. J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000564 · Cited by 19
Increased odds of metabolic syndrome among adults with depressive symptoms or antidepressant use
Meshkat, S., Duffy, S. F., Tassone, V. K., Lin, Q., Pang, H. Y. M., Jung, H., Lou, W. Y. W., & Bhat, V. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03289-4 · Cited by 25
Modulation of PKA, PKC, CAMKII, ERK 1/2 pathways is involved in the acute antidepressant-like effect of (octylseleno)-xylofuranoside (OSX) in mice
Brod, L. M. P., Fronza, M. G., Vargas, J. P., Lüdtke, D. S., Brüning, C. A., & Savegnago, L. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4505-5 · Cited by 20
Discovery of new antidepressant agents: In vivo study on Anthemis wiedemanniana Fisch. & Mey
Dereli, F. T. G., İlhan, M., & Akkol, E. K. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.07.019 · Cited by 19
Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report
Yrondi, A., Fiori, L., Frey, B., Lam, R. W., MacQueen, G., Milev, R., Müller, D. J., Foster, J., Kennedy, S., & Turecki, G. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz066 · Cited by 16
A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort
Bet, P., Verbeek, E. C., Milaneschi, Y., Straver, D. B. M., Uithuisje, T., Bevova, M., Hugtenburg, J., Heutink, P., Penninx, B., & Hoogendijk, W. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.38 · Cited by 17
Self-citation
Should I, can I, dare I? Patients’ view on stopping long-term antidepressant use, a qualitative study
Leeuwen, E. V., Anthierens, S., van Driel, M., Sutter, A. D., Beir, R. D., & Christiaens, T. (2022) · Acta Clinica Belgica · doi:10.1080/17843286.2021.2024384 · Cited by 17
The relationship between self-reported mental health and redeemed prescriptions of antidepressants: a register-based cohort study
Frandsen, L. S., Villumsen, L. B., Hjorth, C. F., Nielsen, B. J., Ullits, L. R., Torp-Pedersen, C. T., Bøggild, H., & Overgaard, C. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0893-7 · Cited by 17
Nx4 Modulated Resting-State Functional Connectivity Between Amygdala and Prefrontal Cortex in a Placebo-Controlled, Crossover Trial
Chand, T., Alizadeh, S., Li, M., Fan, Y., Jamalabadi, H., Danyeli, L. V., Nanni‐Zepeda, M., Herrmann, L., van der Meer, J. N., Vester, J., et al. (2022) · Brain Connectivity · doi:10.1089/brain.2021.0189 · Cited by 16
Antidepressants overuse in primary care: Prescription trends between 2010 and 2019 in Catalonia
Anmella, G., Sanabra, M., Primé‐Tous, M., Segú, X., Solanes, A., Ruíz, V., Morilla, I., Fontanet, A. A., Sant, E., Murgui, S., et al. (2022) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2022.12.001 · Cited by 16
Common CYP2D6, CYP2C9, and CYP2C19 Gene Variants, Health Anxiety, and Neuroticism Are Not Associated With Self-Reported Antidepressant Side Effects
Maggo, S. D. S., Kennedy, M. A., Barczyk, Z. A., Miller, A. L., Rucklidge, J. J., Mulder, R., & Foulds, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01199 · Cited by 20
Effects of Voluntary Running Wheel Exercise-Induced Extracellular Vesicles on Anxiety
Yoon, K. J., Park, S., Kwak, S. H., & Moon, H. Y. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.665800 · Cited by 15
An acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line rat.
Gericke, J., Lekhooa, M., Steyn, S. F., Viljoen, A. M., & Harvey, B. H. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114550 · Cited by 16
Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin
Tabaac, B. J., Shinozuka, K., Arenas, A., Beutler, B. D., Cherian, K. N., Evans, V. D., Fasano, C., & Muir, O. S. (2024) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001724 · Cited by 16
Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression
Manosso, L. M., Moretti, M., Colla, A. R. D. S., Ribeiro, C. M., Dal-Cim, T. A., Tasca, C. I., & Rodrigues, A. L. S. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1504-3 · Cited by 15
Targeting Gap Junctions: New Insights into the Treatment of Major Depressive Disorder
Sarrouilhe, D., Mesnil, M., & Dejean, C. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180327103530 · Cited by 15
Validation of Smartphone Based Heart Rate Tracking for Remote Treatment of Panic Attacks
Mcginnis, R., McGinnis, E. W., Petrillo, C. J., Ferri, J., Scism, J., & Price, M. S. (2020) · IEEE journal of biomedical and health informatics · doi:10.1109/jbhi.2020.3001573 · Cited by 18
Evidence for the involvement of heme oxygenase-1 in the antidepressant-like effect of zinc
Manosso, L. M., Moretti, M., Rosa, J. M., Cunha, M. P., & Rodrigues, A. L. S. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.010 · Cited by 15
Effects of Xingpi Kaiyu Fang on ATP, Na/K-ATPase, and Respiratory Chain Complexes of Hippocampus and Gastrocnemius Muscle in Depressed Rats
Yuan, Q., Li, Y., Deng, X., Shi, H., Zhao, Z., Wang, C., Feng, X.-G., Guo, J., & Guo, R. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/6054926 · Cited by 16
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Gates, M. L., Wilkins, T., Ferguson, E. H., Walker, V., Bradford, R. K., & Yoo, W. (2016) · Health & Justice · doi:10.1186/s40352-016-0037-7 · Cited by 14
Long‐Term Use and Safety of Migraine Preventive Medications
VanderPluym, J. H., Evans, R. W., & Starling, A. J. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12891 · Cited by 14
Antidepressant prescriptions and mental health nurses: an observational study in Dutch general practice from 2011 to 2015
Magnée, T., Beurs, D. P. D., Schellevis, F., & Verhaak, P. F. M. (2018) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2018.1426145 · Cited by 13
Identifying and Managing Anxiety Disorders in Primary Care
Brahmbhatt, A., Richardson, L. G., & Prajapati, S. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.10.019 · Cited by 18

Authors: Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., & Hoogendijk, W. J. G.
Affiliations: Amsterdam Neuroscience (NL)
Amsterdam Public Health (NL)
University Medical Center Groningen (NL)
Erasmus MC (NL)
Corresponding author: Bet, Pierre M.
ORCID: Bet, Pierre M.
Hugtenburg, Jacqueline G.
Penninx, Brenda W.J.H.
Hoogendijk, Witte J.G.
Venue: European Neuropsychopharmacology
Publisher: Elsevier BV
Published: 2013-11
Volume: 23
Issue: 11
Pages: 1443-1451
ISSN: 0924-977X (ISSN-L)
DOI: 10.1016/j.euroneuro.2013.05.001
OpenAlex: W2080820439
Cited by: 239
References: 38
Citations by year: 2026: 18 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 20 · 2021: 24 · 2020: 22 · 2019: 18 · 2018: 17 · 2017: 17 · 2016: 24 · 2015: 11 · 2014: 13
FWCI: 11.75
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Neuropsychopharmacology (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
VU Research Portal (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion)
Leiden Repository (Leiden University) (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: antidepressant side effects, long-term antidepressant use, tricyclic antidepressants, selective serotonin reuptake inhibitors, venlafaxine, mirtazapine, anticholinergic effects, weight gain, sexual dysfunction, depression severity, antidepressant dose, sex differences, NESDA
MeSH terms: Adult, Aged, Aging, Antidepressive Agents, Tricyclic, Dose-Response Relationship, Drug, Female, Humans, Longitudinal Studies, Male, Middle Aged, Netherlands, Severity of Illness Index, Time Factors, Selective Serotonin Reuptake Inhibitors, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Side effects of antidepressants during long-term use in a naturalistic setting

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks